C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) C07K 14/54 (2006.01) C07K 14/715 (2006.01) C07K 16/24 (2006.01) C07K 16/46 (2006.01) C12N 5/18 (2006.01) G01N 33/564 (2006.01) G01N 33/577 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2208503
Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.
L'invention porte sur des anticorps monoclonaux (mAbs) chimériques humanisés anti-interleukine-5 (IL-5) et sur d'autres dérivés de mAbs neutralisants, à haute affinité, sur des préparations pharmaceutiques les contenant, et sur des méthodes de traitement et de diagnostic associées.
Ames Robert S.
Appelbaum Edward Robert
Chaiken Irwin M.
Cook Richard M.
Gross Mitchell Stuart
Glaxosmithkline Llc
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
Smithkline Beecham P.l.c.
LandOfFree
Recombinant il-5 antagonists useful in treatment of il-5... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant il-5 antagonists useful in treatment of il-5..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant il-5 antagonists useful in treatment of il-5... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1881194